Cargando…
Synthesis, Anti-tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones
A SAR translation strategy adopted for the discovery of tetrahydroisoquinolinone (THIQ)-based steroidomimetic microtubule disruptors has been extended to dihydroisoquinolinone (DHIQ)-based compounds. A steroid A,B-ring-mimicking DHIQ core was connected to methoxyaryl D-ring mimics through methylene,...
Autores principales: | Leese, Mathew P, Jourdan, Fabrice L, Major, Meriel R, Dohle, Wolfgang, Thomas, Mark P, Hamel, Ernest, Ferrandis, Eric, Mahon, Mary F, Newman, Simon P, Purohit, Atul, Potter, Barry V L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114533/ https://www.ncbi.nlm.nih.gov/pubmed/24596315 http://dx.doi.org/10.1002/cmdc.201400017 |
Ejemplares similares
-
Steroidomimetic Tetrahydroisoquinolines
for the Design
of New Microtubule Disruptors
por: Leese, Mathew P., et al.
Publicado: (2011) -
Tetrahydroisoquinoline Sulfamates as Potent Microtubule
Disruptors: Synthesis, Antiproliferative and Antitubulin Activity
of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure
por: Dohle, Wolfgang, et al.
Publicado: (2019) -
Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
por: Stengel, C, et al.
Publicado: (2010) -
An efficient route to N-alkylated 3,4-dihydroisoquinolinones with substituents at the 3-position
por: Tazawa, Aoi, et al.
Publicado: (2018) -
In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer
por: Stengel, C, et al.
Publicado: (2014)